Clinical Trial Update: A Long-term Study of ADYNOVI/ADYNOVATE in Participants With Haemophilia A

View source ↗

Summary

A long-term extension trial of ADYNOVI and ADYNOVATE in participants with Hemophilia A is currently active but not recruiting, sponsored by Baxalta now part of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• ADYNOVATE (efmoroctocog alfa)
• ADYNOVI (recombinant antihemophilic factor VIII Fc fusion protein)

Snippet

Sponsor: Baxalta now part of Shire | Conditions: Hemophilia A | Status: ACTIVE_NOT_RECRUITING